West Family Investments Inc. Purchases Shares of 1,266 Synopsys, Inc. $SNPS

West Family Investments Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,266 shares of the semiconductor company’s stock, valued at approximately $565,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Sankala Group LLC purchased a new position in shares of Synopsys in the 4th quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. IMG Wealth Management Inc. acquired a new position in Synopsys during the second quarter worth about $28,000. Caitong International Asset Management Co. Ltd purchased a new position in Synopsys in the 4th quarter valued at approximately $28,000. Finally, Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys in the fourth quarter valued at $32,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analysts Set New Price Targets

SNPS has been the subject of several research reports. Citigroup lifted their price objective on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research report on Wednesday. Needham & Company LLC reiterated a “buy” rating and issued a $580.00 target price on shares of Synopsys in a report on Thursday, May 28th. BNP Paribas Exane boosted their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Synopsys has an average rating of “Moderate Buy” and an average price target of $563.59.

View Our Latest Report on SNPS

Synopsys Stock Performance

SNPS stock opened at $401.24 on Thursday. The stock’s 50 day simple moving average is $422.02 and its 200 day simple moving average is $440.99. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $615.79. The firm has a market cap of $76.83 billion, a P/E ratio of 92.88, a P/E/G ratio of 2.38 and a beta of 1.23.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling

In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.